Selena Kwan Hao, NP
Nurse Practitioner · Milpitas
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Selena Kwan Hao’s office at (408) 945-2900 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
Medicaid work
$854 in 2023
Medicaid paid $854 for 483 billed services this clinician did in 2023, up to 60 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 206 | $518 |
| Short return visit (20+ min) | 208 | $332 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 17 | $5 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 14 | $0 |
| Hemoglobin A1C level | 25 | $0 |
| Long return visit (40+ min) | 13 | $0 |
| 2023 | 483 | 6 | 60 | $854 |
| 2022 | 1,089 | 5 | 83 | $2,839 |
| 2021 | 1,086 | 4 | 63 | $2,080 |
| 2020 | 489 | 5 | 78 | $2,020 |
| 2019 | 188 | 2 | 58 | $22,439 |
| 2018 | 361 | 1 | 63 | $69,534 |
See the largest Medicaid services in earlier years
2022
| Short return visit (20+ min) | 626 | $1,479 |
| Return visit (30+ min) | 334 | $1,155 |
| Long return visit (40+ min) | 43 | $122 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 73 | $83 |
| Hemoglobin A1C level | 13 | $0 |
2021
| Return visit (30+ min) | 496 | $1,275 |
| Short return visit (20+ min) | 477 | $791 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 29 | $14 |
| Long return visit (40+ min) | 84 | $0 |
2020
| Short return visit (20+ min) | 185 | $713 |
| Return visit (30+ min) | 194 | $677 |
| Short return visit | 55 | $381 |
| Long return visit (40+ min) | 40 | $240 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 15 | $10 |
2019
| Clinic visit/encounter, all-inclusive | 118 | $22,280 |
| Return visit (30+ min) | 70 | $159 |
2018
| Clinic visit/encounter, all-inclusive | 361 | $69,534 |
Drugs they prescribed that Part D paid
$19,121
Pharmacies billed $19,121 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
520 generic and 89 brand-name prescriptions · $19,121 in drug cost · 89 antibiotic prescriptions to 77 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Alvesco | 20 | $1,700 | $85 |
| Amlodipine Besylate | 64 | $723 | $11 |
| Albuterol Sulfate Hfa | 32 | $519 | $16 |
| Atorvastatin | 33 | $389 | $12 |
| Losartan | 19 | $301 | $16 |
See all 13 drugs
| Alvesco | 20 | $1,700 | $85 |
| Amlodipine Besylate | 64 | $723 | $11 |
| Albuterol Sulfate Hfa | 32 | $519 | $16 |
| Atorvastatin | 33 | $389 | $12 |
| Losartan | 19 | $301 | $16 |
| Ibuprofen | 25 | $287 | $11 |
| Mupirocin | 17 | $254 | $15 |
| Doxycycline Monohydrate | 24 | $227 | $9 |
| Fluticasone Propionate | 12 | $221 | $18 |
| Lisinopril | 17 | $196 | $12 |
| Amoxicillin-Clavulanate Potass | 12 | $137 | $11 |
| Nitrofurantoin Mono-Macro | 14 | $125 | $9 |
| Prednisone | 17 | $120 | $7 |
Year by year
| 2024 | 621 | 345 | None | 14% | $19,121 |
| 2023 | 752 | 122 | None | 19% | $133,118 |
| 2022 | 658 | 95 | None | None | $98,277 |
| 2021 | 692 | 97 | None | 12% | $67,486 |
| 2020 | 600 | 103 | 3% (17) | None | $45,215 |
| 2019 | 114 | 25 | 0% (0) | None | $4,434 |
| 2018 | 251 | 48 | 0% (0) | None | $12,834 |
| 2017 | 23 | None | 0% (0) | None | $619 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Januvia | 19 | $31,246 | $1,645 |
| Ozempic | 16 | $21,001 | $1,313 |
| Lantus Solostar | 11 | $11,923 | $1,084 |
| Basaglar Kwikpen U-100 | 25 | $8,353 | $334 |
| Gabapentin | 20 | $997 | $50 |
| Clobetasol Propionate | 14 | $981 | $70 |
| Amlodipine Besylate | 59 | $911 | $15 |
| Atorvastatin | 37 | $907 | $25 |
| Losartan | 37 | $852 | $23 |
| Diclofenac | 14 | $711 | $51 |
| Nano 2nd Gen Pen Needle | 11 | $557 | $51 |
| Levothyroxine | 21 | $540 | $26 |
| Albuterol Sulfate Hfa | 19 | $528 | $28 |
| Aripiprazole | 12 | $509 | $42 |
| Omeprazole | 14 | $485 | $35 |
| Simvastatin | 16 | $428 | $27 |
| Metformin | 24 | $369 | $15 |
| Alendronate | 12 | $350 | $29 |
| Glipizide | 21 | $292 | $14 |
| Fluticasone Propionate | 18 | $236 | $13 |
2022: 16 drugs
| Januvia | 21 | $23,228 | $1,106 |
| Ozempic | 11 | $13,094 | $1,190 |
| Basaglar Kwikpen U-100 | 13 | $5,167 | $397 |
| Ventolin Hfa | 17 | $1,064 | $63 |
| Albuterol Sulfate Hfa | 18 | $813 | $45 |
| Atorvastatin | 39 | $642 | $16 |
| Gabapentin | 16 | $454 | $28 |
| Baclofen | 13 | $436 | $34 |
| Amlodipine Besylate | 41 | $399 | $10 |
| Losartan | 24 | $320 | $13 |
| Trazodone | 17 | $262 | $15 |
| Simvastatin | 20 | $187 | $9 |
| Metformin | 23 | $178 | $8 |
| Atenolol | 16 | $124 | $8 |
| Lisinopril | 14 | $117 | $8 |
| Glipizide | 17 | $61 | $4 |
2021: 13 drugs
| Januvia | 12 | $17,754 | $1,479 |
| Omeprazole | 23 | $695 | $30 |
| Atorvastatin | 33 | $656 | $20 |
| Diclofenac | 11 | $513 | $47 |
| Losartan | 44 | $502 | $11 |
| Fluticasone Propionate | 15 | $301 | $20 |
| Amlodipine Besylate | 35 | $289 | $8 |
| Metformin | 39 | $288 | $7 |
| Hydrochlorothiazide | 31 | $207 | $7 |
| Glipizide | 19 | $139 | $7 |
| Trazodone | 11 | $138 | $13 |
| Furosemide | 14 | $116 | $8 |
| Lisinopril | 16 | $110 | $7 |
2020: 14 drugs
| Lantus Solostar | 11 | $4,534 | $412 |
| Omeprazole | 32 | $491 | $15 |
| Losartan | 30 | $411 | $14 |
| Atorvastatin | 21 | $335 | $16 |
| Metformin | 32 | $229 | $7 |
| Gabapentin | 11 | $229 | $21 |
| Hydrochlorothiazide | 19 | $203 | $11 |
| Ibuprofen | 12 | $146 | $12 |
| Trazodone | 13 | $138 | $11 |
| Amlodipine Besylate | 21 | $128 | $6 |
| Simvastatin | 16 | $120 | $7 |
| Lisinopril | 15 | $118 | $8 |
| Metoprolol | 12 | $117 | $10 |
| Glipizide | 11 | $59 | $5 |
2019: 2 drugs
| Atorvastatin | 14 | $124 | $9 |
| Metformin | 12 | $76 | $6 |
2018: 6 drugs
| Gabapentin | 13 | $220 | $17 |
| Tamsulosin | 12 | $206 | $17 |
| Fluticasone Propionate | 12 | $125 | $10 |
| Atorvastatin | 16 | $117 | $7 |
| Metformin | 12 | $75 | $6 |
| Lisinopril | 12 | $51 | $4 |
Money from drug and device companies
$21 in 2023
| 2023 | 1 | 1 | None | $21 |
| 2021 | 1 | 1 | None | $17 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Dexcom | Dexcom G6 Transmitter | $21 | 1 payment
|
See the published payment
| Dexcom | Meals · 2023-06-27 | Dexcom G6 Transmitter | $21 |
See earlier years (2021)
2021: $17
| Medtronic | Linq II | $17 | 1 payment
|
Professional record
- NPI
- 1376067280
- Licence
- CA 845064, CA 95007048
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X); Federal specialty code 163W00000X (163W00000X)
- Mailing address
- 770 E Calaveras Blvd, Milpitas, CA, 95035
- NPI first listed
- 2017-08-01
- NPI last updated
- 2023-10-12
- NPI record certified
- 2023-10-12
This is when the NPI record was last certified, not a medical board exam.